Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-27.19	32.87	45.15
Graham Fair Price	35.18	11.07	8.19
PEG	-71.07	-0.04	0.15
Price/Book	-21.71	1.44	1.84
Price/Cash Flow	13.94	23.54	20.66
Prices/Earnings	-54.43	11.91	-26.13
Price/Sales	-28.24	2.26	3.15
Price/FCF	13.94	23.54	20.66
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-3.62	0.30	0.31
Operating Margin	18680.63	0.06	< 0.005
ROA	68.23	0.01	< 0.005
ROE	-0.02	0.03	71.80
ROIC	< 0.005	0.02	10994.83
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.05	0.56	-91.91
Dividends QOQ	-0.97	16.51	1599.54
EBIT QOQ	-0.99	210.39	21076.31
EPS QOQ	-1.77	2.78	57.51
FCF QOQ	0.20	-0.29	48.37
Revenue QOQ	0.09	0.13	35.23
Naive Interpretation	member

03 - Financial Growth · Best

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	111.71	100.51	-10.03
Days Sales Outstanding (DSO)	39.65	42.55	7.32
Inventory Turnover	0.81	0.90	11.14
Debt/Capitalization	0.39	0.37	-4.74
Quick Ratio	0.82	0.81	-0.64
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	13.00	13.41	3.13
Cash	6.54	6.55	0.23
Capex	-0.14	-0.09	37.80
Free Cash Flow	1.16	0.82	-29.14
Revenue	7.59	8.54	12.51
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.37	1.36	-1.21
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	3.53	2.03	-42.61
Naive Interpretation	Member

06 - Financial Health · Weak

Rating